Kei Yamamoto

发表

Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

Yuji Saito, B. Berk, J. Haendeler, 2001, Molecular and Cellular Biology.

Angiogenesis Induced by Human Hepatocyte Growth Factor Gene Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice : Therapeutic Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene

M. Aoki, T. Ogihara, Y. Kaneda, 2002 .

Gene Therapy for Myocardial Infarction: A Real Medicine in the Next Millenium?

Y. Taniyama, M. Aoki, K. Matsumoto, 2000 .

Ribozyme Oligonucleotides Against Transforming Growth Factor-&bgr; Inhibited Neointimal Formation After Vascular Injury in Rat Model: Potential Application of Ribozyme Strategy to Treat Cardiovascular Disease

M. Aoki, T. Ogihara, Y. Kaneda, 2000, Circulation.

Targeted gene therapy for rat glomerulonephritis using HVJ‐immunoliposomes

T. Ogihara, Y. Kaneda, R. Morishita, 2002, The journal of gene medicine.

Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells

T. Ogihara, Y. Kaneda, R. Morishita, 2001, Hypertension.

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system

H. Makino, M. Tuck, M. Nyby, 2008, Journal of hypertension.

Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats.

Keiko Matsumoto, M. Tuck, M. Nyby, 2005, American journal of hypertension.

Functional Analysis of Tissue Renin-Angiotensin System Using “Gain and Loss of Function” Approaches: In Vivo Test of in Vitro Hypothesis

T. Ogihara, R. Morishita, J. Higaki, 1998 .

Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-κB (NF-κB)–Mediated bcl-2 Suppression In Vivo Evidence of the Importance of NF-κB in Endothelial Cell Regulation

Y. Taniyama, T. Ogihara, R. Morishita, 2000 .

Oligonucleotide-Based Gene Therapy for Cardiovascular Disease

Y. Taniyama, K. Matsumoto, T. Ogihara, 1998, Clinical chemistry and laboratory medicine.

Phosphorylation of p 38 Mitogen-Activated Protein Kinase Downstream of Bax-Caspase-3 Pathway Leads to Cell Death Induced by High D-Glucose in Human Endothelial Cells

Y. Taniyama, M. Aoki, T. Ogihara, 2001 .

N141I mutant presenilin-2 gene enhances neuronal cell death and decreases bcl-2 expression.

T. Ogihara, Y. Kaneda, R. Morishita, 2002, Life sciences.

Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.

Y. Taniyama, M. Aoki, T. Ogihara, 2002, Diabetes.

Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells

Y. Taniyama, M. Aoki, K. Matsumoto, 2001, Hypertension.

Endothelial Apoptosis Induced by Oxidative Stress Through Activation of NF-&kgr;B: Antiapoptotic Effect of Antioxidant Agents on Endothelial Cells

M. Aoki, T. Ogihara, Y. Kaneda, 2001, Hypertension.

Fluid Shear Stress Attenuates Hydrogen Peroxide–Induced c-Jun NH2-Terminal Kinase Activation via a Glutathione Reductase–Mediated Mechanism

Yuji Saito, C. Baines, B. Berk, 2002, Circulation research.

Suppression of cyclooxygenase‐2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid

Shozo Yamamoto, Jining Wang, S. Yamamoto, 2000, FEBS letters.

Anti‐apoptotic action of hepatocyte growth factor through mitogen‐activated protein kinase on human aortic endothelial cells

Y. Taniyama, M. Aoki, T. Ogihara, 2000, Journal of hypertension.

Transcription factor decoy for nuclear factor‐κB inhibits tumor necrosis factor‐α‐induced expression of interleukin‐6 and intracellular adhesion molecule‐1 in endothelial cells

M. Aoki, T. Ogihara, R. Morishita, 1998, Journal of hypertension.

Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: role of Bcl-2, Bcl-xL and Bax in tubular injury.

Y. Taniyama, T. Ogihara, R. Morishita, 2004, International Journal of Molecular Medicine.

Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis.

M. Aoki, T. Ogihara, Y. Kaneda, 1998, Hypertension.

Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells.

Y. Taniyama, M. Aoki, T. Ogihara, 2001, Diabetes.

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease

Y. Taniyama, M. Aoki, K. Matsumoto, 2001, Gene Therapy.

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.

Y. Kaneda, R. Morishita, T. Ochi, 1999, Arthritis and rheumatism.

Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy

T. Ogihara, Y. Kaneda, R. Morishita, 2001, Gene Therapy.

Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.

Y. Taniyama, M. Aoki, T. Nakamura, 2000, Hypertension.

Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.

K. Matsumoto, T. Nakamura, T. Ogihara, 1998, Kidney international.

Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells.

K. Matsumoto, T. Nakamura, T. Ogihara, 1999, Circulation.